Evidence map›Paper›PMID 29848571›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.

Shilpa Bhatia, Jaspreet Sharma, Sanjana Bukkapatnam, Ayman Oweida, Shelby Lennon, Andy Phan, Dallin Milner, Nomin Uyanga, Antonio Jimeno, David Raben and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Theranostic Potential ofIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Shilpa Bhatia *Department of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Jaspreet Sharma *Department of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Sanjana BukkapatnamDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Ayman OweidaDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Shelby LennonDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Andy PhanDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Dallin MilnerDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Nomin UyangaDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Antonio JimenoDivision of Medical Oncology, Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
David RabenDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Hilary SomersetDepartment of Pathology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Lynn HeasleyDepartment of Craniofacial Biology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Sana D KaramDepartment of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado. sana.karam@ucdenver.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Paul Calabresis Award in Clinical Oncology ResearchK12CA086913 · NCI · UNIVERSITY OF COLORADO DENVER · PI VIRGINIA F. BORGES, Jill E Slansky · 2000 to 2026
$17.8M
NCI NIH HHS K12 CA086913NCI NIH HHS P30 CA046934
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisCell Line, TumorCell ProliferationCetuximabCombined Modality TherapyEphrin-B2HumansMiceReceptor, EphB4Signal TransductionSquamous Cell Carcinoma of Head and NeckXenograft Model Antitumor AssaysCetuximabEFNB2 protein, humanEphrin-B2Receptor, EphB4

Identifiers

PMID29848571
PMCPMC6886390
OpenAlexW2807422997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.